Scott Bradley is a seasoned healthcare and life sciences executive with a proven track record of leading product strategy and AI initiatives at both established industry leaders (Novartis, IQVIA, Boston Scientific) and successful startups (CentrosHealth, OM1). His expertise spans machine learning, real-world data, medical device integration, and patient engagement technologies. Scott is a past-president of New England HIMSS and an active board member for the West Point Society of New England, demonstrating his commitment to advancing the healthcare and technology communities. He now leads AI & Innovation at Novartis US.